Related Experiment Video
Updated: May 6, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Tobacco cessation in 2013: what every clinician should know
Carrie Harrill-Smith1, Carol Ripley-Moffitt, Adam O Goldstein
1Corresponding author: Dr. Adam O. Goldstein, Department of Family Medicine, University of North Carolina School of Medicine, Campus Box 7595, Manning Dr., Chapel Hill, NC 27599-7595, USA. aog@med.unc.edu.
Abstract:
Given the many deaths caused by smoking, clinicians should offer evidence-based treatment to every patient who uses tobacco. This commentary discusses health system changes that promote treatment for tobacco use, new protocols for tobacco cessation therapies, and emerging tobacco products that are being marketed as harm-reduction tools.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Peripheral Artery Disease III: Interprofessional Care
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

